Reflow Medical

Focus: Reflow Medical is a newly founded (2024) medical device company focused on catheter and stent systems for cardiovascular and peripheral vascular disease. The company is extremely early-stage with 1-50 employees and is currently in public status.

Unknown Cardiovascular

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Funding Stage

PUBLIC

Employees

1-50

Open Jobs

About Reflow Medical

AI assessmentNot Hiring

No open roles listed right now. Follow Reflow Medical to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

2/9 — Limited

Company HealthSolid

Pipeline

Mid-stage

1 Phase 3+

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Below the Knee peripheral intervention

Critical Limb Ischemia

N/A

Clinical Trials (1)

NCT03669458Feasibility Clinical Trial Using the SPUR System to Demonstrate Safety and Efficacy.

N/A

Help build intelligence for Reflow Medical

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Ground-floor opportunity at a newly founded company (2024) with potential to shape product development and company culture from inception
Focused pipeline in high-need cardiovascular and peripheral vascular markets with multiple device programs spanning coronary and below-the-knee interventions
Small team size (1-50 employees) enables broad exposure across functions and faster individual impact relative to established organizations

Watch Out For

Extreme early-stage risk: newly founded with no disclosed funding, revenue, or financial backing; cash runway and sustainability unknown
Minimal hiring activity with only 3 active roles, all in Sales & Marketing, suggesting limited near-term growth or expansion plans
Unproven management team and execution track record; no commercial products or regulatory approvals to date despite Phase 3 program

Generated by Claude from Reflow Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Drug Eluting Temporary Spur Stent System

Critical Limb Ischemia

N/A

Clinical Trials (1)

NCT06122974Drug Eluting Temporary Spur Stent System vs Percutaneous Balloon Angioplasty for the Treatment of Critical Limb Ischemia

N/A

Wingman Crossing Catheter

Chronic Total Occlusion of Artery of the Extremities

N/A

Clinical Trials (1)

NCT03403426ReFlow Medical Wingman Catheter Wing-IT Clinical Trial

N/A

Vessel recoil measurement 15 minutes post final treatment

Chronic Limb Threatening Ischemia

N/A

Clinical Trials (1)

NCT07465627Vessel Recoil in Specific CLTI Populations

N/A

Temporary Spur Stent System

Peripheral Arterial Disease

N/A

Clinical Trials (1)

NCT03807531A Study of the Temporary Spur Stent for the Treatment of Narrowing and Blockages in the Arteries Below the Knee

N/A

Temporary Spur Stent System

Peripheral Arterial Disease

N/A

Clinical Trials (1)

NCT04162418A Study of the TEmporary Spur StEnt System for the Treatment of Lesions Located in the InfraPoplitEal ARteries Using a LIMUS-base DCB

N/A

Bare Temporary Spur Stent System

Peripheral Arterial Disease

N/A

Clinical Trials (1)

NCT05358353A Prospective Single-Arm Multicenter StuDy of the BarE TEmporary SPur StEnt System foR the tREatment of Vascular Lesions Located in the infrapoplitEal Arteries beLow the Knee (DEEPER REVEAL)

N/A

Drug-eluting Coronary Spur Stent System

In-stent Restenosis

PHASE_1

Clinical Trials (1)

NCT06117150Pilot Study of the Coronary Spur Stent for In-stent Restenosis (DEEPER CORONARY)

Phase 1

coraFlex Catheter

Coronary Occlusion

PHASE_3

Clinical Trials (1)

NCT05848232Single-Arm Study Evaluating Use of the CORA Catheters for the Crossing of Coronary Chronic Total Occlusions